Methotrexate Side Effects
Applies to methotrexate: oral solution, oral tablet. Other dosage forms:
Warning
Oral route (Solution)
Severe Toxic Reactions, Including Embryo-Fetal ToxicityMethotrexate can cause severe or fatal toxicities. Monitor closely and modify dose or discontinue for the following toxicities: bone marrow suppression, infection, renal, gastrointestinal, hepatic, pulmonary, hypersensitivity and dermatologic.Methotrexate can cause embryo-fetal toxicity and fetal death. Use in polyarticular juvenile idiopathic arthritis is contraindicated in pregnancy. Consider the benefits and risks of methotrexate and risks to the fetus when prescribing methotrexate to a pregnant patient with a neoplastic disease. Advise patients to use effective contraception during and after treatment with methotrexate.
Oral route (Solution)
Jylamvo®Warning: Embryo-Fetal Toxicity, Hypersensitivity Reactions, and Severe Adverse ReactionsMethotrexate can cause embryo-fetal toxicity, including fetal death. For non-neoplastic diseases, methotrexate oral solution is contraindicated in pregnancy. For neoplastic diseases, advise females and males of reproductive potential to use effective contraception during and after treatment with methotrexate oral solution.Methotrexate oral solution is contraindicated in patients with a history of severe hypersensitivity reactions to methotrexate, including anaphylaxis.Serious adverse reactions, including death, have been reported with methotrexate. Closely monitor for infections and adverse reactions of the bone marrow, gastrointestinal tract, liver, lungs, skin, and kidneys. Withhold or discontinue methotrexate oral solution as appropriate.
Oral route (Tablet)
Embryo-Fetal Toxicity Hypersensitivity Reactions, and Severe Adverse ReactionsMethotrexate tablets can cause embryo-fetal toxicity, including fetal death. For non-neoplastic diseases, Methotrexate tablets are contraindicated in pregnancy. For neoplastic diseases, advise patients of reproductive potential of the potential risk to a fetus and to use effective contraception.Methotrexate tablets are contraindicated in patients with a history of severe hypersensitivity reactions to methotrexate, including anaphylaxis.Serious adverse reactions, including death, have been reported with methotrexate. Closely monitor for adverse reactions of the bone marrow, gastrointestinal tract, liver, lungs, skin, and kidneys. Withhold or discontinue methotrexate tablets as appropriate.
Serious side effects of Methotrexate
Along with its needed effects, methotrexate may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking methotrexate:
More common
- Black, tarry stools
- bleeding gums
- blood in the urine or stools
- bloody vomit
- diarrhea
- increased heartbeat
- itching, rash, reddening of the skin
- joint pain
- nausea
- pinpoint red spots on the skin
- sores in the mouth or lips
- stomach pain
- swelling of the eyelids, face, lips, hands, feet, or lower legs
- swelling or inflammation of the mouth
- trouble breathing
- unusual bleeding or bruising
- vomiting
- yellow eyes or skin
Less common
- Back pain
- bloody nose
- blurred vision
- body and muscle pain
- burning while urinating
- confusion
- continuing ringing, buzzing, or other unexplained noise in the ears
- cough or hoarseness
- cracked, dry, scaly skin
- dark urine
- dizziness
- drowsiness
- ear congestion
- fever or chills
- headache
- loss of appetite
- loss of hearing
- loss of voice
- lower back or side pain
- painful or difficult urination
- pale skin
- runny nose
- seizures
- sneezing
- sore throat
- stuffy or runny nose
- unusual tiredness or weakness
- weight loss
- white or brownish vaginal discharge
Incidence not known
- Anxiety
- blistering, peeling, or loosening of the skin
- bloating
- blurred or change in vision
- changes in skin color
- confusion
- constipation
- decreased interest in sexual intercourse
- difficulty in moving
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- dry mouth
- dryness or soreness of the throat
- eye pain
- fruit-like breath odor
- heartburn
- inability to have or keep an erection
- increased hunger or thirst
- indigestion
- irritation in the mouth
- large, flat, blue, or purplish patches in the skin
- loss in sexual ability, desire, drive, or performance
- loss of consciousness
- menstrual problem
- night blindness
- pain in the chest or groin
- pain, redness, swelling, or tenderness in the arm or leg
- red skin lesions, often with a purple center
- red, wart-like spots on the skin
- sudden loss of coordination
- sudden onset of slurred speech
- swelling or soreness of the breasts
- swollen, painful, or tender lymph glands in the neck or armpit
- tingling or numbness in the hands, feet, or lips
Other side effects of Methotrexate
Some side effects of methotrexate may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Hair loss or thinning
Less common
- Blemishes on the skin
- hard, red, swollen skin irritation
- pimples
For Healthcare Professionals
Applies to methotrexate: compounding powder, injectable powder for injection, injectable solution, intramuscular solution, oral liquid, oral solution, oral tablet, subcutaneous solution.
General
Frequently observed adverse reactions include ulcerative stomatitis, leukopenia, nausea, and abdominal distress. In addition, infections, malaise, fatigue, chills, fever, and dizziness are commonly reported adverse reactions.[Ref]
Cardiovascular
Rare (0.01% to 0.1%): Pericardial effusion, pericarditis, pericardial tamponade
Postmarketing reports: Thromboembolic events (including arterial thrombosis, cerebral thrombosis, deep vein thrombosis, retinal vein thrombosis, thrombophlebitis, and pulmonary embolus), pericarditis, pericardial effusion, hypotension, sudden death[Ref]
Dermatologic
Common (1% to 10%): Rash, pruritus, dermatitis, alopecia, photosensitivity, burning of skin lesions
Uncommon (0.1% to 1%): Allergic vasculitis, herpetiform eruptions of the skin, Stevens-Johnson´s syndrome, toxic epidermal necrolysis, increase in rheumatoid nodules, increased skin pigmentation, impaired wound healing
Rare (0.01% to 0.1%): Increased nail pigment changes, photo-hypersensitivity, acne petechiae, depigmentation, urticaria, erythema multiforme, painful damage to psoriatic lesion, skin ulceration, onycholysis
Very rare (less than 0.01%): Acute paronychia, telangiectasia, furunculosis, ecchymoses, hidradenitis
Frequency not reported: Skin exfoliation / dermatitis exfoliative
Postmarketing reports: Toxic epidermal necrolysis, Stevens-Johnson syndrome, exfoliative dermatitis, skin necrosis, and erythema multiforme, erythematous rashes, pruritus, alopecia, skin ulceration, accelerated nodulosis, urticaria, pigmentary changes, ecchymosis, telangiectasia, photosensitivity, acne, furunculosis[Ref]
Endocrine
Postmarketing reports: Diabetes[Ref]
Gastrointestinal
Very common (10% or more): Nausea/vomiting (10%), dyspepsia, abdominal pain
Common (1% to 10%): Diarrhea, stomatitis, oral ulcers
Uncommon (0.1% to 1%): Gastrointestinal ulcerations and bleeding
Rare (0.01% to 0.1%): Pancreatitis, gingivitis, enteritis, melena
Very rare (less than 0.01%): Toxic megacolon, hematemesis
Frequency not reported: Anorexia
Postmarketing reports: Hemorrhagic enteritis, intestinal perforation, gingivitis, pancreatitis, pharyngitis, hematemesis, melena, gastrointestinal ulceration[Ref]
Genitourinary
Uncommon (0.1% to 1%): Vaginal inflammation and ulceration
Rare (0.01% to 0.1%): Impotence, menstrual disorders
Very rare (less than 0.01%): Loss of libido, formation of defective oocytes or sperm cells, transient oligospermia, infertility, vaginal discharge, vaginal bleeding, gynecomastia
Frequency not reported: Vaginal discharge
Postmarketing reports: Defective oogenesis or spermatogenesis, loss of libido, impotence, gynecomastia, menstrual dysfunction[Ref]
Hematologic
Common (1% to 10%): Thrombocytopenia (platelet count less than 100,000/mm3), leukopenia (white blood cell count less than 3000/mm3), pancytopenia, anemia
Uncommon (0.1% to 1%): Bone marrow depression, agranulocytosis, hematopoietic disorders
Rare (0.01% to 0.1%): Megaloblastic anemia, hypotension
Very rare (less than 0.01%): Hypogammaglobulinemia, aplastic anemia, lympho-proliferative disorder, neutropenia, lymphadenopathy, vasculitis
Frequency not reported: Decreased hematocrit, eosinophilia
Postmarketing reports: Aplastic anemia, lymphadenopathy, hypogammaglobulinemia[Ref]
Hepatic
Very common (10% or more): Elevated liver function tests (15%)
Uncommon (0.1% to 1%): Cirrhosis, fibrosis and fatty degeneration of the liver, decrease in serum albumin
Rare (0.01% to 0.1%): Hepatotoxicity, acute hepatitis
Very rare (less than 0.01%): Reactivation of chronic hepatitis, hepatic failure
Postmarketing reports: Acute hepatitis, decreased serum albumin, fibrosis, cirrhosis, liver failure[Ref]
Immunologic
Uncommon (0.1% to 1%): Anaphylactic-type reaction, allergic reactions, anaphylactic shock
Very rare (less than 0.01%): Immuno-suppression
Postmarketing reports: Anaphylaxis, anaphylactoid reactions, vasculitis[Ref]
Metabolic
Uncommon (0.1% to 1%): Diabetes mellitus
Postmarketing reports: Hyperglycemia[Ref]
Musculoskeletal
Rare (0.01% to 0.1%): Osteoporosis, arthralgia, myalgia
Very rare (less than 0.01%): Stress fracture
Frequency not reported: Osteonecrosis of jaw (secondary to lymphoproliferative disorders)
Postmarketing reports: Stress fracture, soft tissue necrosis, arthralgia, myalgia, osteoporosis[Ref]
Nervous system
Common (1% to 10%): Dizziness, headache, fatigue, drowsiness
Uncommon (0.1% to 1%): Convulsions, vertigo
Rare (0.01% to 0.1%): Hemiparesis, paresis
Very rare (less than 0.01%): Cerebral edema, acute aseptic meningitis with meningism (paralysis, vomiting), irritation, dysarthria, aphasia, lethargy, transient subtle cognitive dysfunction, dysarthria, unusual cranial sensations, pain, muscular asthenia, paresthesia/ hypoesthesia, changes in sense of taste (metallic taste)
Frequency not reported: Encephalopathy/leukoencephalopathy
Postmarketing reports: Headaches, drowsiness, blurred vision, speech impairment (including dysarthria and aphasia), transient cognitive dysfunction, mood alteration, unusual cranial sensations, paresis, encephalopathy, leukoencephalopathy, convulsions, spinal radiculopathy (with intrathecal use)[Ref]
Ocular
Rare (0.01% to 0.1%): Severe visual disturbances
Very rare (less than 0.01%): Conjunctivitis, impaired vision, retinopathy
Frequency not reported: Eye discomfort
Postmarketing reports: Optic neuropathy, blurred vision, ocular irritation, conjunctivitis, xerophthalmia[Ref]
Oncologic
Uncommon (0.1% to 1%): Lymphoma[Ref]
Other
Uncommon (0.1% to 1%): Chills
Frequency not reported: Fever, infection, sweating, tinnitus[Ref]
Psychiatric
Uncommon (0.1% to 1%): Depression, confusion
Rare (0.01% to 0.1%): Mood swings
Very rare (less than 0.01%): Insomnia[Ref]
Renal
Uncommon (0.1% to 1%): Disturbed micturition, inflammation and ulceration of the urinary bladder (possibly with hematuria), renal insufficiency, nephropathy
Rare (0.01% to 0.1%): Oliguria, anuria, electrolyte disturbances
Very rare (less than 0.01%): Dysuria, azotemia, cystitis, hematuria, proteinuria
Postmarketing reports: Azotemia, hematuria, proteinuria, cystitis[Ref]
Respiratory
Common (1% to 10%): Interstitial pneumonitis
Uncommon (0.1% to 1%): Nosebleed, interstitial fibrosis
Rare (0.01% to 0.1%): Respiratory paralysis, dyspnea, pharyngitis, bronchial asthma
Very rare (less than 0.01%): Chronic interstitial obstructive lung disease, pleuritis, dry cough, pleural effusion
Frequency not reported: Upper respiratory infection, chest pain, coughing, epistaxis, alveolitis, pulmonary alveolar hemorrhage
Postmarketing reports: Pulmonary fibrosis, respiratory failure, chronic interstitial obstructive pulmonary disease, pleuritic pain and thickening, alveolitis[Ref]
Frequently asked questions
- Why should I take folic acid with methotrexate?
- How do I know if methotrexate is working for rheumatoid arthritis?
- Does it cause weight gain?
- How long does it take to work?
- What are the different brands of methotrexate?
- What causes Plaque Psoriasis?
- How long does methotrexate stay in your system?
- How does methotrexate work for ectopic pregnancy?
More about methotrexate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (328)
- Drug images
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: antimetabolites
- Breastfeeding
Patient resources
- Methotrexate drug information
- Methotrexate injection
- Methotrexate (Injection, Subcutaneous) (Advanced Reading)
- Methotrexate (Oral) (Advanced Reading)
- Methotrexate Injection (Subcutaneous)
Other brands
Rasuvo, Trexall, Otrexup, Xatmep, ... +3 more
Professional resources
Related treatment guides
References
1. Cerner Multum, Inc. UK Summary of Product Characteristics.
2. Cerner Multum, Inc. Australian Product Information.
3. Product Information. Methotrexate Sodium (methotrexate). Teva Pharmaceuticals (formerly IVAX). 2017.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.